IRADIMED CORP (IRMD:NASDAQ)
$93.4 -2.16 (-2.2604%)
Analysed IRADIMED CORP (IRMD:NASDAQ) News Sources
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
10-04-2026
yahoo.com
3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes
23-03-2026
yahoo.com
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
16-03-2026
yahoo.com
Why The IRADIMED (IRMD) Story Is Shifting As Analysts Update Targets And Guidance Arrives
13-03-2026
yahoo.com
5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside
10-03-2026
yahoo.com
Here’s What Offers IRadimed Corp. (IRMD) a Compelling Growth Trajectory
20-02-2026
yahoo.com
IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter
17-02-2026
fool.com
Resolute Holdings Stock Soars 400% as Nine Ten Trims $5 Million From Stake
17-02-2026
fool.com
3 Undiscovered Gems In The US Market To Consider For Your Portfolio
11-02-2026
yahoo.com
iRadimed Corp (IRMD) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
10-02-2026
yahoo.com
What is the current price of IRADIMED CORP (IRMD:NASDAQ)?
The current price of IRADIMED CORP (IRMD:NASDAQ) is $93.4.
IRADIMED CORP (IRMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of IRADIMED CORP (IRMD:NASDAQ) since the previous trading day is $-2.16.
IRADIMED CORP (IRMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of IRADIMED CORP (IRMD:NASDAQ) since the previous trading day is -2.2604%.
What is the most recent average sentiment score for IRADIMED CORP (IRMD:NASDAQ)?
The most recent average sentiment score for IRADIMED CORP (IRMD:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for IRADIMED CORP (IRMD:NASDAQ)?
The most recent sentiment for IRADIMED CORP (IRMD:NASDAQ) is .
SEC-8K** Filing Available For IRADIMED CORP (IRMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.